Crossmark

Psoriasis, PsA und HS: IL-17A/F-Inhibitor in neuer Dosierung verfügbar

Crossref DOI link: https://doi.org/10.1007/s15012-024-8626-y

Published Online: 2024-11-20

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-11-01
More Information

Article History

First Online: 20 November 2024

Free to read: This content has been made available to all.